These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
388 related items for PubMed ID: 8623229
1. Different immunosuppressive effects of liposomal FK506 in liver and kidney transplantation. Ko S, Nakajima Y, Kanehiro H, Horikawa M, Yoshimura A, Kido K, Taki J, Aomatsu Y, Kin T, Yagura K, Ohyama T, Ohashi K, Yamada T, Nakano H. Transplant Proc; 1996 Apr; 28(2):1066-8. PubMed ID: 8623229 [Abstract] [Full Text] [Related]
2. Predominant role of local immunosuppressive effect in enhanced efficacy of liposomal FK506 in organ transplantation. Ko S, Nakajima Y, Kanehiro H, Hisanaga M, Horikawa M, Aomatsu Y, Yagura K, Kin T, Ohyama T, Nishio K, Yamada T, Nakano H. Transplant Proc; 1997 Apr; 29(1-2):529-31. PubMed ID: 9123117 [Abstract] [Full Text] [Related]
3. The enhanced immunosuppressive efficacy of newly developed liposomal FK506 in canine liver transplantation. Ko S, Nakajima Y, Kanehiro H, Horikawa M, Yoshimura A, Taki J, Aomatsu Y, Kin T, Yagura K, Nakano H. Transplantation; 1995 May 27; 59(10):1384-8. PubMed ID: 7539553 [Abstract] [Full Text] [Related]
4. Significance of newly developed liposomal FK 506 in canine liver transplantation. Ko S, Nakajima Y, Kanehiro H, Horikawa M, Yoshimura A, Taki J, Kido K, Aomatsu Y, Ueno M, Kin T. Transplant Proc; 1995 Feb 27; 27(1):351-3. PubMed ID: 7533406 [No Abstract] [Full Text] [Related]
5. Comparative studies of FK506 and cyclosporine in canine orthotopic hepatic allograft survival. Yokota K, Takishima T, Sato K, Osakabe T, Nakayama Y, Uchida H, Aso K, Masaki Y, Ohbu M, Okudaira M. Transplant Proc; 1989 Feb 27; 21(1 Pt 1):1066-8. PubMed ID: 2468209 [No Abstract] [Full Text] [Related]
7. TIRC7 is induced in rejected human kidneys and anti-TIRC7 mAb with FK506 prolongs survival of kidney allografts in rats. Kumamoto Y, Tamura A, Volk HD, Reinke P, Löhler J, Tullius SG, Utku N. Transpl Immunol; 2006 Nov 27; 16(3-4):238-44. PubMed ID: 17138060 [Abstract] [Full Text] [Related]
9. Conversion from cyclosporine to tacrolimus in hepatic and renal transplantation. Yussim A, Shaharabani E, Mor E, Lustig S, Bar-Nathan N, Shmueli D, Sobolev V, Dorfman B, Or H, Shapira Z. Transplant Proc; 1996 Dec 27; 28(6):3178-9. PubMed ID: 8962233 [No Abstract] [Full Text] [Related]
10. Correlation between simplified immunocompetence assay and clinical graft states in kidney or liver transplant recipients. Shinozuka N, Koyama I, Omoto R, Burdick J. Transplant Proc; 1996 Jun 27; 28(3):1259. PubMed ID: 8658649 [No Abstract] [Full Text] [Related]
11. [Implantation of FK506 drug delivery system into the anterior chamber for inhibiting corneal rejection in high risk rabbit corneal allograft]. Shi WY, Liu T, Xie LX, Wang SG. Zhonghua Yan Ke Za Zhi; 2006 Apr 27; 42(4):299-304. PubMed ID: 16762204 [Abstract] [Full Text] [Related]
15. Relationship of whole-blood FK506 concentrations to rejection and toxicity in liver and kidney transplants. Hedayat S, Kershner RP, Su G. J Biopharm Stat; 1996 Nov 27; 6(4):411-24. PubMed ID: 8969977 [Abstract] [Full Text] [Related]
16. FK506 effectiveness in reducing acute rejection after heart transplantation: a prospective randomized study. Rinaldi M, Pellegrini C, Martinelli L, Goggi C, Gavazzi A, Campana C, Arbustini E, Grossi P, Regazzi M, Ippoliti G, Vigano M. J Heart Lung Transplant; 1997 Oct 27; 16(10):1001-10. PubMed ID: 9361242 [Abstract] [Full Text] [Related]